2,586 research outputs found
Second-Generation Curvelets on the Sphere
Curvelets are efficient to represent highly anisotropic signal content, such as a local linear and curvilinear structure. First-generation curvelets on the sphere, however, suffered from blocking artefacts. We present a new second-generation curvelet transform, where scale-discretized curvelets are constructed directly on the sphere. Scale-discretized curvelets exhibit a parabolic scaling relation, are well localized in both spatial and harmonic domains, support the exact analysis and synthesis of both scalar and spin signals, and are free of blocking artefacts. We present fast algorithms to compute the exact curvelet transform, reducing computational complexity from O(L5) to O(L3 log2 L) for signals band limited at L. The implementation of these algorithms is made publicly available. Finally, we present an illustrative application demonstrating the effectiveness of curvelets for representing directional curve-like features in natural spherical images
Not all light transmission aggregation assays are created equal: qualitative differences between light transmission and 96-well plate aggregometry.
In this short article, submitted as part of the review on platelet function testing, we illustrate the quantitative and qualitative differences between classical light transmission aggregometry (LTA) and 96-well plate aggregometry. We show that responses to platelet agonists and antagonists differ depending upon the method of aggregation testing. For example, in 96-well aggregometry, responses to collagen are strongly inhibited by P2Y12 receptor antagonists while in LTA they are much less affected. Furthermore, we explore the importance of differences in the mechanical environment upon platelet aggregation. We emphasize that LTA and 96-well aggregometry are not interchangeable assays. These two assays are best used as complementary tests to explore platelet function in depth
P2Y12 receptor blockade synergises strongly with nitric oxide and prostacyclin to inhibit platelet activation.
Combination of cyclic nucleotide modulators with P2Y12 receptor antagonists as anti-platelet therapy
"This is the peer reviewed version of the following article: Armstrong, PC,Ā Ferreira, PM,Ā Chan, MV, et al.Ā Combination of cyclic nucleotide modulators with P2Y12Ā receptor antagonists as antiāplatelet therapy.Ā J Thromb Haemost.Ā 2020Ā https://doi.org/10.1111/jth.14826 which has been published in final form at Ā Ā https://doi.org/10.1111/jth.14826BACKGROUND: Endothelium-derived prostacyclin and nitric oxide elevate platelet cyclic nucleotide levels and maintain quiescence. We previously demonstrated that a synergistic relationship exists between cyclic nucleotides and P2Y12 receptor inhibition. A number of clinically approved drug classes can modulate cyclic nucleotide tone in platelets including activators of NO-sensitive guanylyl cyclase (GC) and phosphodiesterase (PDE) inhibitors. However, the doses required to inhibit platelets produce numerous side effects including headache. OBJECTIVE: We investigated using GC-activators in combination with P2Y12 receptor antagonists as a way to selectively amplify the anti-thrombotic effect of both drugs. METHODS: In vitro light transmission aggregation and platelet adhesion under flow were performed on washed platelets and platelet rich plasma. Aggregation in whole blood and a ferric chloride-induced arterial thrombosis model were also performed. RESULTS: The GC-activator BAY-70 potentiated the action of the P2Y12 receptor inhibitor prasugrel active metabolite in aggregation and adhesion studies and was associated with raised intra-platelet cyclic nucleotide levels. Furthermore, mice administered sub-maximal doses of the GC activator cinaciguat together with the PDE inhibitor dipyridamole and prasugrel, showed significant inhibition of ex vivo platelet aggregation and significantly reduced in vivo arterial thrombosis in response to injury without alteration in basal carotid artery blood flow. CONCLUSIONS: Using in vitro, ex vivo, and in vivo functional studies, we show that low dose GC activators synergize with P2Y12 inhibition to produce powerful anti-platelet effects without altering blood flow. Therefore, modulation of intra-platelet cyclic nucleotide levels alongside P2Y12 inhibition can provide a strong, focused anti-thrombotic regimen while minimizing vasodilator side effects
A picogram and nanometer scale photonic crystal opto-mechanical cavity
We describe the design, fabrication, and measurement of a cavity
opto-mechanical system consisting of two nanobeams of silicon nitride in the
near-field of each other, forming a so-called "zipper" cavity. A photonic
crystal patterning is applied to the nanobeams to localize optical and
mechanical energy to the same cubic-micron-scale volume. The picrogram-scale
mass of the structure, along with the strong per-photon optical gradient force,
results in a giant optical spring effect. In addition, a novel damping regime
is explored in which the small heat capacity of the zipper cavity results in
blue-detuned opto-mechanical damping.Comment: 15 pages, 4 figure
Antiplatelet effects of aspirin vary with level of P2Y(12) receptor blockade supplied by either ticagrelor or prasugrel
Pan-GWAS of Streptococcus agalactiae Highlights Lineage-Specific Genes Associated with Virulence and Niche Adaptation
Streptococcus agalactiae (group B streptococcus; GBS) is a colonizer of the gastrointestinal and urogenital tracts, and an opportunistic pathogen of infants and adults. The worldwide population of GBS is characterized by clonal complexes (CCs) with different invasive potentials. CC17, for example, is a hypervirulent lineage commonly associated with neonatal sepsis and meningitis, while CC1 is less invasive in neonates and more commonly causes invasive disease in adults with comorbidities. The genetic basis of GBS virulence and the extent to which different CCs have adapted to different host environments remain uncertain. We have therefore applied a pan-genome-wide association study (GWAS) approach to 1,988 GBS strains isolated from different hosts and countries. Our analysis identified 279 CC-specific genes associated with virulence, disease, metabolism, and regulation of cellular mechanisms that may explain the differential virulence potential of particular CCs. In CC17 and CC23, for example, we have identified genes encoding pilus, quorum-sensing proteins, and proteins for the uptake of ions and micronutrients which are absent in less invasive lineages. Moreover, in CC17, carriage and disease strains were distinguished by the allelic variants of 21 of these CC-specific genes. Together our data highlight the lineage-specific basis of GBS niche adaptation and virulence.IMPORTANCE GBS is a leading cause of mortality in newborn babies in high- and low-income countries worldwide. Different strains of GBS are characterized by different degrees of virulence, where some are harmlessly carried by humans or animals and others are much more likely to cause disease.The genome sequences of almost 2,000 GBS samples isolated from both animals and humans in high- and low- income countries were analyzed using a pan-genome-wide association study approach. This allowed us to identify 279 genes which are associated with different lineages of GBS, characterized by a different virulence and preferred host. Additionally, we propose that the GBS now carried in humans may have first evolved in animals before expanding clonally once adapted to the human host.These findings are essential to help understand what is causing GBS disease and how the bacteria have evolved and are transmitted
Stoichiometry of a regulatory splicing complex revealed by single-molecule analyses
Splicing is regulated by complex interactions of numerous RNA-binding proteins. The molecular mechanisms involved remain elusive, in large part because of ignorance regarding the numbers of proteins in regulatory complexes. Polypyrimidine tract-binding protein (PTB), which regulates tissue-specific splicing, represses exon 3 of Ī±-tropomyosin through distant pyrimidine-rich tracts in the flanking introns. Current models for repression involve either PTB-mediated looping or the propagation of complexes between tracts. To test these models, we used single-molecule approaches to count the number of bound PTB molecules both by counting the number of bleaching steps of GFP molecules linked to PTB within complexes and by analysing their total emissions. Both approaches showed that five or six PTB molecules assemble. Given the domain structures, this suggests that the molecules occupy primarily multiple overlapping potential sites in the polypyrimidine tracts, excluding propagation models. As an alternative to direct looping, we propose that repression involves a multistep process in which PTB binding forms small local loops, creating a platform for recruitment of other proteins that bring these loops into close proximity
Factors which modulate platelet reactivity as measured by five assay platforms in 3,429 individuals
- ā¦